ADMA files Form 144 for RSU-related common stock sales

ADMA Biologics submitted a Form 144 notice proposing the sale of Common Stock.

Rhea-AI Filing Summary

ADMA Biologics submitted a Form 144 notice proposing the sale of Common Stock. The filing lists multiple blocks of restricted stock units scheduled to vest on specific dates, including 15,162 shares vesting 06/26/2024 and another 15,162 shares vesting 06/26/2025. The broker/agent listed is Fidelity Brokerage Services, LLC (10b5-1 Group).

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does ADMA's Form 144 disclose about the securities?

The Form 144 lists proposed sales of Common Stock tied to RSU vesting events. It details specific vesting dates and share counts, such as 15,162 shares vesting on 06/26/2024 and other scheduled vesting blocks noted in the filing.

Who is the broker or agent handling the proposed sales for ADMA (ADMA)?

The filing identifies Fidelity Brokerage Services, LLC, Attention: 10b5-1 Group as the broker/agent. The notice lists Fidelity's Merrimack, NH address and references the 10b5-1 trading group as the handling unit for these transactions.

How many shares are shown as vesting on the filing's key dates?

The filing shows several RSU vesting amounts: 15,162 shares vesting on 06/26/2024, another 15,162 shares on 06/26/2025, 7,220 shares on 02/26/2025, 10,977 shares on 07/25/2025, and 1,505 shares on 02/19/2026.

Are these shares attributable to compensation-related awards for ADMA?

Yes. The listed securities are tied to Restricted Stock Units (RSUs) granted on various prior grant dates. Each entry in the filing is labeled as a Compensatory Payment related to RSU vesting on the specified dates.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/10/2026 - 09:45 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002030561
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ADMA BIOLOGICS, INC.
SEC File Number	001-36728
Address of Issuer	465 STATE ROUTE 17 RAMSEY NEW JERSEY 07446
Phone	(201) 478-5552
Name of Person for Whose Account the Securities are To Be Sold	Tade Brad L.
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Former Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Fidelity Brokerage Services, LLC Attention: 10b5-1 Group 2 Contra Way T2L Merrimack NH 03054	50026	790911	238159176	03/10/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	06/26/2024	Restricted Stock Units vesting - granted June 26, 2023	Issuer			15162	06/26/2024	Compensatory Payment
Common Stock	06/26/2025	Restricted Stock Units vesting - granted June 26, 2023	Issuer			15162	06/26/2025	Compensatory Payment
Common Stock	02/26/2025	Restricted Stock Units vesting - granted February 26, 2024	Issuer			7220	02/26/2025	Compensatory Payment
Common Stock	07/25/2025	Restricted Stock Units vesting - granted July 25, 2024	Issuer			10977	07/25/2025	Compensatory Payment
Common Stock	02/19/2026	Restricted Stock Units vesting - granted February 19, 2025	Issuer			1505	02/19/2026	Compensatory Payment

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	03/10/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Brad L. Tade
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)